Charcot–Marie–Tooth disease

GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $300,000 investment in a groundbreaking gene editing project aimed at tackling CMT2A, the most common axonal type of Charcot-Marie-Tooth disease. The …

GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $90,860 investment in a groundbreaking two-year research project at the University of California, San Diego (UC San Diego). Led by Dr. …